1. Nat Genet. 2000 Jun;25(2):141-2. doi: 10.1038/75977.

Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton 
syndrome.

Chavanas S(1), Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine AD, Bonafé 
JL, Wilkinson J, Taïeb A, Barrandon Y, Harper JI, de Prost Y, Hovnanian A.

Author information:
(1)The Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, 
UK.

We describe here eleven different mutations in SPINK5, encoding the serine 
protease inhibitor LEKTI, in 13 families with Netherton syndrome (NS, 
MIM256500). Most of these mutations predict premature termination codons. These 
results disclose a critical role of SPINK5 in epidermal barrier function and 
immunity, and suggest a new pathway for high serum IgE levels and atopic 
manifestations.

DOI: 10.1038/75977
PMID: 10835624 [Indexed for MEDLINE]